K Shawn Davison

Summary

Publications

  1. ncbi request reprint Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays
    Jacques P Brown
    2086 Byron St, Victoria, BC V8R 1L9
    Can Fam Physician 60:324-33. 2014
  2. ncbi request reprint The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future
    K Shawn Davison
    Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
    Semin Arthritis Rheum 36:10-21. 2006
  3. ncbi request reprint Bone strength: the whole is greater than the sum of its parts
    K Shawn Davison
    Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
    Semin Arthritis Rheum 36:22-31. 2006
  4. pmc Measurement equivalence of the SF-36 in the Canadian Multicentre Osteoporosis Study
    Lisa M Lix
    School of Public Health, University of Saskatchewan, Saskatoon, Canada
    Health Qual Life Outcomes 10:29. 2012
  5. doi request reprint Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis
    Claudie Berger
    CaMos Methods Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 25:1948-57. 2010
  6. doi request reprint Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD
    Lisa Langsetmo
    CaMos National Coordinating Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:1515-22. 2009
  7. doi request reprint Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels
    Claudie Berger
    CaMos Coordinating Centre, McGill University, 687 Pine Avenue West, Montreal, Quebec, Canada
    J Bone Miner Res 27:1381-9. 2012
  8. doi request reprint Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond
    K Shawn Davison
    Department of Medicine, Division of Rheumatology and Immunology, Laval University, Quebec, PQ, Canada
    Am J Med 122:992-7. 2009
  9. ncbi request reprint Changes to osteoporosis prevalence according to method of risk assessment
    J Brent Richards
    Department of Medicine, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 22:228-34. 2007
  10. doi request reprint Association between change in BMD and fragility fracture in women and men
    Claudie Berger
    CaMos Methods Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:361-70. 2009

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays
    Jacques P Brown
    2086 Byron St, Victoria, BC V8R 1L9
    Can Fam Physician 60:324-33. 2014
    ..To outline the efficacy and risks of bisphosphonate therapy for the management of osteoporosis and describe which patients might be eligible for bisphosphonate "drug holiday."..
  2. ncbi request reprint The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future
    K Shawn Davison
    Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
    Semin Arthritis Rheum 36:10-21. 2006
    ..To summarize the current knowledge regarding the impact of the most common antifracture medications on the various determinants of bone strength...
  3. ncbi request reprint Bone strength: the whole is greater than the sum of its parts
    K Shawn Davison
    Clinical Research Scientist, Department of Medicine, Laval University, Sainte Foy, Quebec, Canada
    Semin Arthritis Rheum 36:22-31. 2006
    ..To summarize the current knowledge regarding the various determinants of bone strength...
  4. pmc Measurement equivalence of the SF-36 in the Canadian Multicentre Osteoporosis Study
    Lisa M Lix
    School of Public Health, University of Saskatchewan, Saskatoon, Canada
    Health Qual Life Outcomes 10:29. 2012
    ..This study examined the measurement equivalence (ME) of the 36-item Medical Outcomes Study Short Form Survey (SF-36), a widely-used measure of HRQOL, by sex and race in a population-based Canadian sample...
  5. doi request reprint Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis
    Claudie Berger
    CaMos Methods Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 25:1948-57. 2010
    ..Furthermore, lack of concordance of PBM and BMD over age 65 suggests different determinants of PBM and subsequent bone loss...
  6. doi request reprint Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD
    Lisa Langsetmo
    CaMos National Coordinating Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:1515-22. 2009
    ..Furthermore, those with a combination of prior low-trauma fracture and another risk factor were at especially high risk of future fracture...
  7. doi request reprint Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels
    Claudie Berger
    CaMos Coordinating Centre, McGill University, 687 Pine Avenue West, Montreal, Quebec, Canada
    J Bone Miner Res 27:1381-9. 2012
    ..We have observed concurrent increasing 25(OH)D levels and decreasing PTH levels over 10 years. Secular increases in supplemental vitamin D intake influenced both changes in serum 25(OH)D and PTH levels...
  8. doi request reprint Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond
    K Shawn Davison
    Department of Medicine, Division of Rheumatology and Immunology, Laval University, Quebec, PQ, Canada
    Am J Med 122:992-7. 2009
    ..This article discusses the assessment of fracture risk in clinical practice, reviews currently and soon-available bone measurement tools, and details the impacts of osteoporosis therapies on fracture risk...
  9. ncbi request reprint Changes to osteoporosis prevalence according to method of risk assessment
    J Brent Richards
    Department of Medicine, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 22:228-34. 2007
    ....
  10. doi request reprint Association between change in BMD and fragility fracture in women and men
    Claudie Berger
    CaMos Methods Centre, McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:361-70. 2009
    ..The results suggest that BMD change should be included with other variables in a comprehensive fracture prediction model to capture its contribution to osteoporotic fracture risk...
  11. doi request reprint Direct medical resource utilization associated with osteoporosis-related nonvertebral fractures in postmenopausal women
    Sonia Jean
    Chronic Disease Surveillance Division, National Institute of Public Health of Quebec, Quebec, Canada
    J Bone Miner Res 28:360-71. 2013
    ..With an aging population and increased prevalence of fractures, strategies for osteoporosis management need to be introduced to reduce the healthcare burden...
  12. doi request reprint Bone turnover markers in the management of postmenopausal osteoporosis
    Jacques P Brown
    Universite Laval, Quebec, QC, Canada
    Clin Biochem 42:929-42. 2009
    ....
  13. ncbi request reprint Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programme
    Louis Bessette
    University of Laval, Department of Rheumatology, Sainte Foy, PQ, Canada
    Contemp Clin Trials 29:194-210. 2008
    ..All participants with fragility or traumatic fractures who consent will be followed for 20 years using data from the Qu├ębec Ministry of Health database to measure the association between the index fracture and future fracture risk...